XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Share-Based Compensation
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
On July 25, 2013, the Company adopted the 2013 Equity Based Stock Compensation Plan (“2013 EBSC Plan”) approved by its shareholders to replace the 2003 Stock Option Plan. The 2013 EBSC Plan provides 1,114,446 shares of common stock for equity based compensation awards including incentive and non-qualified stock options and restricted stock awards. As of June 30, 2022, there were 414,370 shares available for future grants.
Share-Based Compensation Expense
The following table presents share-based compensation expense and the related tax benefits for the periods indicated:
Three Months Ended June 30,
Six Months Ended June 30,
($ in thousands)2022202120222021
Share-based compensation expense related to:
Stock options
$43 $50 $90 $78 
Restricted stock awards
99 67 193 6,129 
Total share-based compensation expense
$142 $117 $283 $207 
Related tax benefits
$31 $21 $60 $41 
The following table presents unrecognized share-based compensation expense as of the date indicated:
June 30, 2022
($ in thousands)Unrecognized ExpenseWeighted-Average Remaining Expected Recognition Period
Unrecognized share-based compensation expense related to:
Stock options
$401 3.3 years
Restricted stock awards
901 3.1 years
Total unrecognized share-based compensation expense
$1,302 3.2 years
Stock Options
The following tables represent stock option activity for the periods indicated:
Three Months Ended June 30, 2022
($ in thousands except per share data)
Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Contractual TermAggregated Intrinsic Value
Outstanding at beginning of period
608,734 $12.24 4.7 years$6,519 
Exercised
(12,097)$7.07 1.6 years
Forfeited
(1,000)$15.50 5.5 years
Outstanding at end of period
595,637 $12.34 4.5 years$3,776 
Exercisable at end of period
481,637 $10.85 3.6 years$3,770 
Six Months Ended June 30, 2022
($ in thousands except per share data)
Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Contractual TermAggregated Intrinsic Value
Outstanding at beginning of period
632,772 $11.47 4.54 years$6,641 
Granted
30,000 $22.61 10.00 years
Exercised
(66,135)$8.57 2.43 years
Forfeited
(1,000)$15.50 5.53 years
Outstanding at end of period
595,637 $12.34 4.50 years$3,776 
Exercisable at end of period
481,637 $10.85 3.58 years$3,770 
The following table represents information regarding unvested stock options for the periods indicated:
Three Months Ended June 30, 2022
Six Months Ended June 30, 2022
Number of SharesWeighted-Average Exercise Price Per ShareNumber of SharesWeighted-Average Exercise Price Per Share
Outstanding at beginning of period
122,000 $18.40 107,099 $16.70 
Granted
— $— 30,000 $22.61 
Vested(7,000)$15.19 (22,099)$14.84 
Forfeited
(1,000)$15.50 (1,000)$15.50 
Outstanding at end of period
114,000 $18.63 114,000 $18.63 
Restricted Stock Awards
The following table represents RSAs activity for the periods indicated:
Three Months Ended June 30, 2022
Six Months Ended June 30, 2022
Number of SharesWeighted-Average Grant Date Fair Value Per ShareNumber of SharesWeighted-Average Grant Date Fair Value Per Share
Outstanding at beginning of period
68,822 $16.51 55,284 $12.79 
Granted
— $— 25,000 $21.96 
Vested— $— (11,262)$10.36 
Forfeited
— $— (200)$17.09 
Outstanding at end of period
68,822 $16.51 68,822 $16.51